Bharat Parenterals Ltd (BPLPHARMA.BO)
- Previous Close
1,319.95 - Open
1,293.60 - Bid --
- Ask 1,293.60 x --
- Day's Range
1,293.60 - 1,293.60 - 52 Week Range
802.00 - 1,590.00 - Volume
207 - Avg. Volume
2,950 - Market Cap (intraday)
8.915B - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
-- - EPS (TTM)
-66.66 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield 1.00 (0.08%)
- Ex-Dividend Date Jun 25, 2024
- 1y Target Est
--
Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India. The company provides products in the areas of antibiotics, anti-retroviral, antiprotozoal/anthelmintic, respiratory, antiallergic/anti-histaminic/anticold, cleansing agents/skin infections, cardiovascular systems, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastrointestinal tract/alimentary systems, anti-inflammatory/anti-pyretic/analgesics, supplements, central nervous system, anaesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer, and others. It also provides general products, ß-lactum /cephalosporin products, and formulations. The company offers its products in the form of tablets, capsules, liquid-orals, ointments, creams, lotions, suspensions, syrups, powders, oral solutions and drops, gels, vaginal inserts, nebulizers, elixiers, eye drops, infusions, nasal drops, and powdered injections, as well as in ampoules and vials. It serves biopharmaceuticals startup and pharmaceutical companies. The company also exports its products internationally. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.
bplindia.in--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: BPLPHARMA.BO
View MorePerformance Overview: BPLPHARMA.BO
Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BPLPHARMA.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BPLPHARMA.BO
View MoreValuation Measures
Market Cap
9.10B
Enterprise Value
10.22B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.67
Price/Book (mrq)
2.75
Enterprise Value/Revenue
3.00
Enterprise Value/EBITDA
71.36
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.71%
Return on Assets (ttm)
-3.54%
Return on Equity (ttm)
-15.14%
Revenue (ttm)
3.4B
Net Income Avi to Common (ttm)
-126.3M
Diluted EPS (ttm)
-66.66
Balance Sheet and Cash Flow
Total Cash (mrq)
679.9M
Total Debt/Equity (mrq)
53.16%
Levered Free Cash Flow (ttm)
-571.5M